Clinical Trial Update: The Safety & Efficacy of Combination BMS-201038 (AEGR-733) & Ezetimibe vs. Monotherapy in Moderate Hypercholesterolemia [Phase 2]

View source ↗

Summary

Phase 2 trial results comparing the safety and efficacy of combining AEGR-733 (BMS-201038) with ezetimibe versus ezetimibe monotherapy in moderate hypercholeste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• BMS-201038 (AEGR-733) (AEGR-733)
• EZETIMIBE (EZETIMIBE)

Snippet

Sponsor: Aegerion Pharmaceuticals, Inc. | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED | Results posted: 2014-03-04